Acquisition Marks New Phase for Advanced Brain Monitoring
ABM was acquired by Cadence Health Capital last month. A new leadership team at the neurology-forward sleep company plans to streamline operations and expand the clinical reach of validated technologies for sleep apnea, insomnia, and neurodegenerative disease.
